Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP15063.RAhNbuDBKeRyVizdv4Ixr7PHdWp6Xuc49UZmey5y_0nMI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP15063.RAhNbuDBKeRyVizdv4Ixr7PHdWp6Xuc49UZmey5y_0nMI130_assertion type Assertion NP15063.RAhNbuDBKeRyVizdv4Ixr7PHdWp6Xuc49UZmey5y_0nMI130_head.
- NP15063.RAhNbuDBKeRyVizdv4Ixr7PHdWp6Xuc49UZmey5y_0nMI130_assertion description "[Patients with CN-AML harboring mutations in NPM1, FLT3, CEBPA, WT1 or expressing high levels of BAALC, ERG, or MN1 have distinctly different clinical outcomes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP15063.RAhNbuDBKeRyVizdv4Ixr7PHdWp6Xuc49UZmey5y_0nMI130_provenance.
- NP15063.RAhNbuDBKeRyVizdv4Ixr7PHdWp6Xuc49UZmey5y_0nMI130_assertion evidence source_evidence_curated NP15063.RAhNbuDBKeRyVizdv4Ixr7PHdWp6Xuc49UZmey5y_0nMI130_provenance.
- NP15063.RAhNbuDBKeRyVizdv4Ixr7PHdWp6Xuc49UZmey5y_0nMI130_assertion SIO_000772 19822134 NP15063.RAhNbuDBKeRyVizdv4Ixr7PHdWp6Xuc49UZmey5y_0nMI130_provenance.
- NP15063.RAhNbuDBKeRyVizdv4Ixr7PHdWp6Xuc49UZmey5y_0nMI130_assertion wasDerivedFrom ctd_human-20130708 NP15063.RAhNbuDBKeRyVizdv4Ixr7PHdWp6Xuc49UZmey5y_0nMI130_provenance.
- NP15063.RAhNbuDBKeRyVizdv4Ixr7PHdWp6Xuc49UZmey5y_0nMI130_assertion wasGeneratedBy ECO_0000218 NP15063.RAhNbuDBKeRyVizdv4Ixr7PHdWp6Xuc49UZmey5y_0nMI130_provenance.